HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AKESO

82.250

+0.3000.37%

Volume:8.22M

Turnover:666.94M

Market Cap:73.86B

PE:-124.61

High:83.200

Open:81.950

Low:79.300

Close:81.950

Loading ...

Overview Company News Filings

BRIEF-Akeso Says NMPA Approved NDA Of Ebdarokimab, Il-12/Il-23

Akeso - Nmpa Approved Nda of Ebdarokimab, Il-12/Il-23

THOMSON REUTERS

BRIEF-Akeso Ebdarokimab Approved In China For Moderate - To - Severe Plaque Psoriasis

Akeso: Ebdarokimab Approved in China for Moderate - to - Severe Plaque Psoriasis

THOMSON REUTERS

The Chinese CEO Who Believes Her Cancer Drug Can Beat Merck's Bestseller -- WSJ

Chinese Biotech Stocks Outshine Tech Rally on Robust Earnings

Akeso Swings to Loss in 2024

MT Newswires Live

Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape With Bispecific Antibodies

THOMSON REUTERS

Press Release: Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies

Akeso's Penpulimab Receives Nmpa Approval for First-Line Treatment of Nasopharyngeal Cancer

THOMSON REUTERS

Akeso, Inc.'s (HKG:9926) Shares Climb 28% But Its Business Is Yet to Catch Up

Simply Wall St.

Akeso Announces the Publication of Its Phase Iii Clinical Trial Results for Ivonescimab in Head-to-Head Comparison With Pembrolizumab in the Lancet

THOMSON REUTERS

Akeso Announces Completion of Patient Enrollment in the Phase Iii Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma

THOMSON REUTERS

Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for "IO 2.0 + ADC" Strategy

THOMSON REUTERS

Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination With Pfizer's Adcs

THOMSON REUTERS

Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos

Akeso Announces Ind Acceptance for Ak139, a Bispecific Antibody Targeting Il-4RΑ and St2 for Respiratory and Skin Diseases

THOMSON REUTERS

Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in Nsclc

THOMSON REUTERS

The Drug Industry Is Having Its Own DeepSeek Moment -- Heard on the Street -- WSJ

Akeso Announces the Completion of Patient Enrollment in the Phase Iii Clinical Trial (Harmoni-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-Nsclc

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/09926/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09926","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","market":"HK","secType":"STK","nameCN":"AKESO","latestPrice":82.25,"timestamp":1749197316022,"preClose":81.95,"halted":0,"volume":8223023,"delay":0,"floatShares":898000000,"shares":898000000,"eps":-0.6600590704069544,"marketStatus":"Market Closed","change":0.3,"latestTime":"06-06 16:08:36","open":81.95,"high":83.2,"low":79.3,"amount":666942323,"amplitude":0.04759,"askPrice":82.3,"askSize":15000,"bidPrice":82.25,"bidSize":8000,"shortable":3,"etf":0,"ttmEps":-0.6600590704069544,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749432600000},"marketStatusCode":7,"adr":0,"listingDate":1587657600000,"exchange":"SEHK","adjPreClose":81.95,"openAndCloseTimeList":[[1749173400000,1749182400000],[1749186000000,1749196800000]],"volumeRatio":0.4654475104217684,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","floatShares":898000000,"roa":"-4.16%","roe":"-8.89%","lyrEps":-0.660059,"volumeRatio":0.4654475104217684,"shares":898000000,"dividePrice":0,"high":83.2,"amplitude":0.04759,"preClose":81.95,"low":79.3,"week52Low":35,"pbRate":"9.93","psRate":"31.85","week52High":105.5,"institutionHeld":0,"latestPrice":82.25,"committee":-0.304348,"eps":-0.6600590704069544,"divideRate":0,"volume":8223023,"delay":0,"ttmEps":-0.6600590704069544,"open":81.95,"prevYearClose":60.7,"prevWeekClose":83.8,"prevMonthClose":83.8,"prevQuarterClose":76.2,"fiveDayClose":83.8,"twentyDayClose":84.35,"sixtyDayClose":72.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09926\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529879804","title":"BRIEF-Akeso Says NMPA Approved NDA Of Ebdarokimab, Il-12/Il-23","url":"https://stock-news.laohu8.com/highlight/detail?id=2529879804","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529879804?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:27","pubTimestamp":1745231265,"startTime":"0","endTime":"0","summary":"BRIEF-Akeso Says NMPA Approved NDA Of Ebdarokimab, Il-12/Il-23April 21 (Reuters) - Akeso 9926.HK:NMPA APPROVED NDA OF EBDAROKIMAB, IL-12/IL-23Further company coverage: 9926.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nFWN3QZ064:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0348784397.USD","BK1161","09926","LU1720050803.USD","LU2488822045.USD","BK1574","LU0417516571.SGD","LU0348783233.USD","LU1794554557.SGD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2529769878","title":"Akeso - Nmpa Approved Nda of Ebdarokimab, Il-12/Il-23","url":"https://stock-news.laohu8.com/highlight/detail?id=2529769878","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529769878?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:15","pubTimestamp":1745230511,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nFWN3QZ064:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","LU0417516571.SGD","BK1574","LU0348784397.USD","BK1161","LU0348783233.USD","LU1794554557.SGD","LU1720050803.USD","IE00BPRC5H50.USD","09926","IE00B5MMRT66.SGD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2528067496","title":"BRIEF-Akeso Ebdarokimab Approved In China For Moderate - To - Severe Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2528067496","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528067496?lang=en_us&edition=fundamental","pubTime":"2025-04-18 22:18","pubTimestamp":1744985903,"startTime":"0","endTime":"0","summary":"BRIEF-Akeso Ebdarokimab Approved In China For Moderate - To - Severe Plaque PsoriasisApril 18 (Reuters) - Akeso Inc 9926.HK:AKESO: EBDAROKIMAB APPROVED IN CHINA FOR MODERATE - TO - SEVERE PLAQUE PSORI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nFWN3QV3AL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","09926","LU2488822045.USD","LU1720050803.USD","LU1794554557.SGD","LU0348784397.USD","IE00BPRC5H50.USD","BK1574","LU0417516571.SGD","LU0348783233.USD","BK1161","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2528063865","title":"Akeso: Ebdarokimab Approved in China for Moderate - to - Severe Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2528063865","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528063865?lang=en_us&edition=fundamental","pubTime":"2025-04-18 19:42","pubTimestamp":1744976541,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nFWN3QV3AL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B543WZ88.USD","BK1161","LU0348783233.USD","BK1574","09926","LU0417516571.SGD","LU2488822045.USD","LU0348784397.USD","LU1720050803.USD","IE00B5MMRT66.SGD","LU1794554557.SGD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2526562641","title":"The Chinese CEO Who Believes Her Cancer Drug Can Beat Merck's Bestseller -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2526562641","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526562641?lang=en_us&edition=fundamental","pubTime":"2025-04-12 08:00","pubTimestamp":1744416000,"startTime":"0","endTime":"0","summary":"Amid the worst U.S.-China trade clash in modern history, Michelle Xia thinks she has something Chinese that Americans will want.It isn't a $3 T-shirt or an electronic gadget. It is a cancer drug her company discovered -- one that has made her the face of a rising pharmaceutical star.When Xia founded her company with three colleagues in 2012, China had few labs capable of finding drugs on their own, while U.S. companies filled their research departments with Chinese scientists. Xia, born in China's northwestern province of Gansu, had been one of them: She did cancer research at the University of Louisville and worked in the U.S. for companies including Bayer.It nagged at her that her home country had little to match the modern medical feats achieved in the West.\" said Xia, 58 years old, in an interview.The population was growing richer and older, spelling opportunity. Xia's three co-founders all had lengthy experience in the U.S., including Baiyong Li, who spent 12 years at P","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU0234572021.USD","09926","LU1989771016.USD","LU1116320901.HKD","LU0265550359.USD","LU1037948541.HKD","BK4007","LU1699723380.USD","BK4559","LU1061106388.HKD","LU1057294990.SGD","LU1571399168.USD","LU2023250843.SGD","LU0861579265.USD","IE0009355771.USD","SG9999001440.SGD","SG9999002224.SGD","LU1037948897.HKD","LU1929549753.HKD","LU1066053197.SGD","LU1934455277.USD","SG9999015341.SGD","SG9999015358.SGD","IE00BJJMRZ35.SGD","BK4533","IE000M9KFDE8.USD","LU2361045086.USD","LU1585245621.USD","IE00B543WZ88.USD","LU2361044865.SGD","LU0965509283.SGD","LU2324357040.USD","LU2361044949.HKD","LU2461242641.AUD","IE00B4R5TH58.HKD","IE00BN8TJ469.HKD","LU1983299246.USD","MRK","LU2089984988.USD","LU0965509010.AUD","LU0208291251.USD","LU0965509101.SGD","LU2112291526.USD","LU1066051811.HKD","LU0238689110.USD","LU1162221912.USD","BK4516","LU0265550946.USD","LU0320765646.SGD"],"gpt_icon":0},{"id":"1148796507","title":"Chinese Biotech Stocks Outshine Tech Rally on Robust Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1148796507","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148796507?lang=en_us&edition=fundamental","pubTime":"2025-04-01 13:03","pubTimestamp":1743483824,"startTime":"0","endTime":"0","summary":"Chinese biotechnology stocks rallied on Tuesday, driven by better-than-expected earnings from key players and investors seeking defensive sectors ahead of the looming US tariffs.Shares of $Akeso Inc.(","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bloomberg.com/news/articles/2025-04-01/chinese-biotech-stocks-advance-on-better-earnings-more-deals","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1584095487587","symbols":["03347","09926","02359","03759","02269","06606"],"gpt_icon":1},{"id":"2523164917","title":"Akeso Swings to Loss in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2523164917","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523164917?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:07","pubTimestamp":1743419274,"startTime":"0","endTime":"0","summary":"Akeso  swung to an attributable loss of 514.5 million yuan in 2024 from a profit of 2.03 billion yuan in 2023, according to a Sunday filing with the Hong Kong bourse.The biopharmaceuticals producer swung to a loss per share of 0.60 yuan from earnings per share of 2.42 yuan in the previous year.Revenue declined 53% to 2.12 billion yuan from 4.53 billion yuan a year earlier.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BPRC5H50.USD","LU1720050803.USD","LU0348784397.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2488822045.USD","09926","LU0417516571.SGD","BK1161","LU0348783233.USD","BK1574","LU1794554557.SGD"],"gpt_icon":0},{"id":"2523021988","title":"Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape With Bispecific Antibodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2523021988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523021988?lang=en_us&edition=fundamental","pubTime":"2025-03-31 02:32","pubTimestamp":1743359543,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250330:nTUA8WGGKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU0348783233.USD","BK1574","LU0348784397.USD","IE00BPRC5H50.USD","09926","LU0417516571.SGD","LU2488822045.USD","BK1161","LU1794554557.SGD","LU1720050803.USD"],"gpt_icon":0},{"id":"2523988027","title":"Press Release: Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2523988027","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523988027?lang=en_us&edition=fundamental","pubTime":"2025-03-31 02:32","pubTimestamp":1743359520,"startTime":"0","endTime":"0","summary":"Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies. -- Global first \"immuno + anti-vascular\" bispecific antibody approved:. ivonescimab for EGFR-TKI resistant nsq-NSCLC. Phase III HARMONi study. -- ivonescimab outperforms pembrolizumab in Phase III study for first-line. PD-L1+ NSCLC: mPFS HR=0.51; sNDA under priority review.-- Cadonilimab approved for first-line gastric cancer: Fills immunotherapy. gap for patients with low or negative PD-L1 expression.-- New commercial milestones: cadonilimab and ivonescimab added to the. -- AK117  enters Phase III trials: ivonescimab combined with AK117 for. On the commercial front, Akeso's adjustments in drug pricing and optimization of its commercial systems led to new drug sales revenue surpassing RMB 2 billion in 2024, a 25% year-on-year increase. The company continues to reduce operating losses, with an EBITDA loss of 225 million RMB in 2024.\"We are thrilled to have reac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348784397.USD","LU0053666078.USD","LU1794554557.SGD","LU0348783233.USD","BK1161","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU2488822045.USD","LU0417516571.SGD","BK4585","BK4107","BK4588","IE00BPRC5H50.USD","09926","BK1574","LU1720050803.USD","L"],"gpt_icon":0},{"id":"2520285554","title":"Akeso's Penpulimab Receives Nmpa Approval for First-Line Treatment of Nasopharyngeal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2520285554","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520285554?lang=en_us&edition=fundamental","pubTime":"2025-03-17 11:49","pubTimestamp":1742183395,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nTUA23GYV9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B543WZ88.USD","LU0417516571.SGD","LU2488822045.USD","BK1574","09926","IE00BPRC5H50.USD","LU0348784397.USD","LU1720050803.USD","IE00B5MMRT66.SGD","BK1161","LU1794554557.SGD","LU0348783233.USD"],"gpt_icon":0},{"id":"2519320395","title":"Akeso, Inc.'s (HKG:9926) Shares Climb 28% But Its Business Is Yet to Catch Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2519320395","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519320395?lang=en_us&edition=fundamental","pubTime":"2025-03-16 08:35","pubTimestamp":1742085344,"startTime":"0","endTime":"0","summary":"Akeso, Inc. ( HKG:9926 ) shareholders would be excited to see that the share price has had a great month, posting a 28...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-incs-hkg9926-shares-climb-28-but-its-business-is-yet-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B543WZ88.USD","LU1794554557.SGD","BK1574","09926","LU2488822045.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU0348783233.USD","BK1161","LU0348784397.USD","LU0417516571.SGD","LU1720050803.USD"],"gpt_icon":0},{"id":"2517129678","title":"Akeso Announces the Publication of Its Phase Iii Clinical Trial Results for Ivonescimab in Head-to-Head Comparison With Pembrolizumab in the Lancet","url":"https://stock-news.laohu8.com/highlight/detail?id=2517129678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517129678?lang=en_us&edition=fundamental","pubTime":"2025-03-07 13:04","pubTimestamp":1741323844,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nTUA5CG3YM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0417516571.SGD","BK1161","LU0348784397.USD","LU1720050803.USD","IE00B543WZ88.USD","LU0348783233.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU1794554557.SGD","09926","BK1574","LU2488822045.USD"],"gpt_icon":0},{"id":"2517979311","title":"Akeso Announces Completion of Patient Enrollment in the Phase Iii Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2517979311","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517979311?lang=en_us&edition=fundamental","pubTime":"2025-03-06 08:30","pubTimestamp":1741221002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nTUA48VPCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","BK1161","LU0348783233.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1720050803.USD","LU1794554557.SGD","IE00BPRC5H50.USD","LU0348784397.USD","BK1574","09926","LU0417516571.SGD"],"gpt_icon":0},{"id":"2514270658","title":"Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for \"IO 2.0 + ADC\" Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2514270658","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514270658?lang=en_us&edition=fundamental","pubTime":"2025-02-27 16:58","pubTimestamp":1740646720,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nTUA82CJGQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B543WZ88.USD","09926","LU2488822045.USD","LU1720050803.USD","LU1794554557.SGD","LU0348784397.USD","IE00BPRC5H50.USD","BK1574","LU0417516571.SGD","LU0348783233.USD","BK1161","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2514086204","title":"Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination With Pfizer's Adcs","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086204","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514086204?lang=en_us&edition=fundamental","pubTime":"2025-02-25 09:14","pubTimestamp":1740446043,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nTUA8P9HQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU0348783233.USD","BK1574","LU0348784397.USD","IE00BPRC5H50.USD","09926","LU0417516571.SGD","LU2488822045.USD","BK1161","LU1794554557.SGD","LU1720050803.USD"],"gpt_icon":0},{"id":"2513408847","title":"Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos","url":"https://stock-news.laohu8.com/highlight/detail?id=2513408847","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513408847?lang=en_us&edition=fundamental","pubTime":"2025-02-24 19:44","pubTimestamp":1740397440,"startTime":"0","endTime":"0","summary":"Summit Therapeutics and Pfizer will work together to study Summit's promising cancer drug candidate ivonescimab and Pfizer's antibody drug conjugates, or ADCs, in solid tumors.Summit on Monday said the companies plan to evaluate ivonescimab in combination with several Pfizer ADCs across multiple solid tumor settings to determine the safety profile and potential anti-tumor activity of the combinations.Miami biopharmaceutical company Summit said it will provide ivonescimab for use in the proposed studies, slated to begin in the middle of the year, with New York drugmaker Pfizer being responsible for conducting the studies.Summit has licensed the rights to ivonescimab in North and South America, Europe, the Middle East, Africa and Japan from Chinese biotech Akeso, which engineered the drug.Summit last year reported data from a late-stage study that showed ivonescimab beat Merck's blockbuster cancer drug Keytruda in patients with a form of lung cancer.Pfizer is developing several ADCs, whi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","LU0320765489.SGD","SG9999014542.SGD","LU0965509101.SGD","SG9999001176.USD","LU1035773651.USD","LU0965509283.SGD","BK1161","LU1989772923.USD","LU1794554557.SGD","LU1571399168.USD","LU1069347547.HKD","LU1066051225.USD","LU0306807586.USD","LU1066051811.HKD","SG9999002224.SGD","BK1574","LU0203347892.USD","LU2324357040.USD","LENZ","IE00B2B36J28.USD","BK4007","LU0985481810.HKD","LU0321505868.SGD","SG9999013999.USD","IE0002270589.USD","LU0234572021.USD","LU1023059063.AUD","PFE","LU0348784397.USD","SG9999015358.SGD","SMMF","LU2468319806.SGD","BK4581","IE00BFTCPJ56.SGD","LU0965508806.USD","LU0265550359.USD","BK4533","LU1989772840.SGD","BK4568","LU2461242641.AUD","MRK","SMMT","BK4516","BK4559","09926","LU1941712264.USD","IE00BN8TJ469.HKD","ADC","LU1974910355.USD"],"gpt_icon":0},{"id":"2511500401","title":"Akeso Announces Ind Acceptance for Ak139, a Bispecific Antibody Targeting Il-4RΑ and St2 for Respiratory and Skin Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2511500401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511500401?lang=en_us&edition=fundamental","pubTime":"2025-02-14 09:11","pubTimestamp":1739495509,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nTUA36QPBK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU0348784397.USD","LU0417516571.SGD","BK1161","LU1794554557.SGD","LU0348783233.USD","IE00B5MMRT66.SGD","LU1720050803.USD","09926","LU2488822045.USD"],"gpt_icon":0},{"id":"2511557255","title":"Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2511557255","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511557255?lang=en_us&edition=fundamental","pubTime":"2025-02-13 09:26","pubTimestamp":1739410007,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nTUA7LRSQF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0348783233.USD","LU0348784397.USD","LU0417516571.SGD","LU1720050803.USD","LU2488822045.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU1794554557.SGD","IE00B5MMRT66.SGD","09926","BK1161","BK1574"],"gpt_icon":0},{"id":"2509715922","title":"The Drug Industry Is Having Its Own DeepSeek Moment -- Heard on the Street -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2509715922","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509715922?lang=en_us&edition=fundamental","pubTime":"2025-02-07 18:30","pubTimestamp":1738924200,"startTime":"0","endTime":"0","summary":"The biotech industry's DeepSeek moment came last fall.That is when Summit Therapeutics, backed by billionaire  Bob Duggan, announced that its drug had outperformed Merck's blockbuster therapy Keytruda in a head-to-head lung-cancer trial. Keytruda, a $30 billion-a-year immunotherapy juggernaut, is the bestselling drug in the pharma industry and has long dominated the market. So the prospect of a superior competitor was seismic. Even more remarkable: Summit had licensed the drug just two years earlier from a little known Chinese biotech called Akeso.But Chinese innovation is steadily improving and is already starting to disrupt the U.S. drug-development ecosystem. For decades, the U.S. biotech industry has thrived in hubs such as Boston-Cambridge and the San Francisco Bay Area, fueled by talent streaming from top academic centers like Massachusetts Institute of Technology and Stanford University. Those biotech companies have an insatiable client in Big Pharma, which is willing to pay top","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","VKTX","NVO","09926","SMMT","AZN","03692"],"gpt_icon":1},{"id":"2509267819","title":"Akeso Announces the Completion of Patient Enrollment in the Phase Iii Clinical Trial (Harmoni-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2509267819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509267819?lang=en_us&edition=fundamental","pubTime":"2025-02-06 09:28","pubTimestamp":1738805292,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nTUA27ZLZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BPRC5H50.USD","BK1574","LU0348784397.USD","LU1720050803.USD","LU1794554557.SGD","BK1161","09926","LU0348783233.USD","LU0417516571.SGD","LU2488822045.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":44,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09926\",params:#limit:5,,,undefined,":[{"date":"2025-03-30","symbol":"09926","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743298200000,"name":null,"time":"Post Market","dateTimestamp":1743264000000,"actualEps":null},{"date":"2024-08-28","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null},{"date":"2024-03-18","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710725400000,"name":null,"time":"","dateTimestamp":1710691200000,"actualEps":null},{"date":"2023-08-29","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693272600000,"name":null,"time":"","dateTimestamp":1693238400000,"actualEps":null},{"market":"HK","date":"2023-04-27","symbol":"09926","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1682524800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09926\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09926\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.55,"hold":0.05,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.55,"analysts":20,"updateTime":1745856000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09926\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09926","date":"2025-06-06","current":-131.180073,"percent":0.025556,"low":-163.883348,"twenty":-59.359698,"median":-23.982021,"eighty":13.592632,"high":20.221708,"avg":-27.780549,"sd":34.997742,"marketCap":73825558226},"quantilePoints":[{"date":"2020-06-12","current":-63.276404,"twenty":-59.542646,"median":-55.820181,"eighty":-50.765107,"marketCap":23218186692},{"date":"2020-06-19","current":-68.299799,"twenty":-60.537832,"median":-56.858534,"eighty":-51.676962,"marketCap":25107123914},{"date":"2020-06-26","current":-80.148198,"twenty":-63.334108,"median":-58.348972,"eighty":-52.779632,"marketCap":29435938382},{"date":"2020-07-03","current":-77.885169,"twenty":-66.643902,"median":-58.880358,"eighty":-53.202931,"marketCap":28648881206},{"date":"2020-07-10","current":-76.725563,"twenty":-70.305822,"median":-59.096072,"eighty":-53.649064,"marketCap":28491469771},{"date":"2020-07-17","current":-70.467076,"twenty":-73.692098,"median":-59.898011,"eighty":-54.044506,"marketCap":26209003960},{"date":"2020-07-24","current":-65.539086,"twenty":-72.620808,"median":-60.537717,"eighty":-54.320018,"marketCap":24280713879},{"date":"2020-07-31","current":-65.051015,"twenty":-71.63744,"median":-61.425183,"eighty":-54.696299,"marketCap":24241361020},{"date":"2020-08-07","current":-61.60528,"twenty":-71.199223,"median":-62.665648,"eighty":-55.108469,"marketCap":22982069539},{"date":"2020-08-14","current":-60.398898,"twenty":-70.692859,"median":-61.425183,"eighty":-55.354665,"marketCap":22588540951},{"date":"2020-08-21","current":-65.573062,"twenty":-70.162934,"median":-62.07047,"eighty":-55.490937,"marketCap":24634889608},{"date":"2020-08-28","current":-62.258841,"twenty":-69.624858,"median":-61.507641,"eighty":-55.875802,"marketCap":23572362421},{"date":"2020-09-04","current":-56.454938,"twenty":-69.299363,"median":-61.279481,"eighty":-56.312276,"marketCap":21447308046},{"date":"2020-09-11","current":-59.39532,"twenty":-69.034548,"median":-61.149297,"eighty":-56.381895,"marketCap":22588540951},{"date":"2020-09-18","current":-23.213534,"twenty":-68.783672,"median":-61.157004,"eighty":-56.381895,"marketCap":23847832432},{"date":"2020-09-25","current":-20.580693,"twenty":-68.608413,"median":-60.769842,"eighty":-55.354665,"marketCap":20975073740},{"date":"2020-09-30","current":-21.520592,"twenty":-68.49576,"median":-60.537717,"eighty":-54.51941,"marketCap":22037600928},{"date":"2020-10-09","current":-20.533232,"twenty":-68.261016,"median":-60.351714,"eighty":-53.10451,"marketCap":21329249469},{"date":"2020-10-16","current":-20.579561,"twenty":-67.599319,"median":-60.014098,"eighty":-50.561624,"marketCap":21368602328},{"date":"2020-10-23","current":-18.390768,"twenty":-65.566444,"median":-59.898011,"eighty":-36.752532,"marketCap":19125489376},{"date":"2020-10-30","current":-18.387929,"twenty":-65.53997,"median":-59.39532,"eighty":-22.333682,"marketCap":19125489376},{"date":"2020-11-06","current":-18.960772,"twenty":-65.539086,"median":-59.096072,"eighty":-21.714319,"marketCap":19951899411},{"date":"2020-11-13","current":-17.861227,"twenty":-65.495719,"median":-58.967855,"eighty":-21.20377,"marketCap":18810666506},{"date":"2020-11-20","current":-18.195519,"twenty":-65.439452,"median":-58.396831,"eighty":-20.827083,"marketCap":19282900812},{"date":"2020-11-27","current":-18.163703,"twenty":-65.051015,"median":-57.55027,"eighty":-20.533232,"marketCap":19204195094},{"date":"2020-12-04","current":-19.807773,"twenty":-64.515903,"median":-57.279422,"eighty":-20.022532,"marketCap":21093132316},{"date":"2020-12-11","current":-21.33702,"twenty":-64.452305,"median":-56.818854,"eighty":-20.137955,"marketCap":22667246668},{"date":"2020-12-18","current":-24.630996,"twenty":-64.186949,"median":-56.363634,"eighty":-20.421683,"marketCap":26209003960},{"date":"2020-12-24","current":-26.970119,"twenty":-63.818518,"median":-55.820181,"eighty":-20.432553,"marketCap":28727586924},{"date":"2020-12-31","current":-28.06698,"twenty":-63.629518,"median":-55.339775,"eighty":-20.494047,"marketCap":29908172688},{"date":"2021-01-08","current":-32.570823,"twenty":-63.597221,"median":-55.265323,"eighty":-20.51364,"marketCap":34984691473},{"date":"2021-01-15","current":-37.631162,"twenty":-63.40952,"median":-54.292281,"eighty":-20.570295,"marketCap":40403477353},{"date":"2021-01-22","current":-41.643907,"twenty":-63.295257,"median":-53.301351,"eighty":-20.580467,"marketCap":44693027527},{"date":"2021-01-29","current":-40.849406,"twenty":-63.217929,"median":-51.221035,"eighty":-20.705895,"marketCap":44202793221},{"date":"2021-02-05","current":-42.462881,"twenty":-63.20331,"median":-50.765107,"eighty":-20.737196,"marketCap":45673496138},{"date":"2021-02-11","current":-44.298428,"twenty":-63.199738,"median":-50.518886,"eighty":-20.809106,"marketCap":47716139078},{"date":"2021-02-19","current":-44.620302,"twenty":-63.148699,"median":-50.046102,"eighty":-20.827888,"marketCap":48083814807},{"date":"2021-02-26","current":-38.677591,"twenty":-62.923489,"median":-46.003712,"eighty":-21.003278,"marketCap":41588210258},{"date":"2021-03-05","current":-36.070462,"twenty":-62.63965,"median":-44.620302,"eighty":-21.129156,"marketCap":38687657283},{"date":"2021-03-12","current":-33.577269,"twenty":-62.438134,"median":-44.247826,"eighty":-21.158012,"marketCap":35950515744},{"date":"2021-03-19","current":-35.993074,"twenty":-62.327407,"median":-43.908841,"eighty":-21.185375,"marketCap":38524245848},{"date":"2021-03-26","current":-37.072786,"twenty":-62.202297,"median":-42.138278,"eighty":-21.221991,"marketCap":39504714459},{"date":"2021-04-01","current":-41.283195,"twenty":-62.015041,"median":-41.751169,"eighty":-21.266862,"marketCap":43875970351},{"date":"2021-04-09","current":-31.196593,"twenty":-61.70772,"median":-41.695813,"eighty":-21.319481,"marketCap":43590000339},{"date":"2021-04-16","current":-30.642009,"twenty":-61.527169,"median":-40.849406,"eighty":-21.393706,"marketCap":42977207457},{"date":"2021-04-23","current":-31.96013,"twenty":-61.441675,"median":-40.344151,"eighty":-21.433299,"marketCap":44938144680},{"date":"2021-04-30","current":-30.816187,"twenty":-61.312504,"median":-39.558199,"eighty":-21.441654,"marketCap":43508294622},{"date":"2021-05-07","current":-28.864106,"twenty":-61.27851,"median":-38.69692,"eighty":-21.489217,"marketCap":41016270235},{"date":"2021-05-14","current":-29.343194,"twenty":-61.208677,"median":-38.024901,"eighty":-21.636828,"marketCap":41669915976},{"date":"2021-05-21","current":-32.815059,"twenty":-61.158545,"median":-37.656345,"eighty":-21.839766,"marketCap":46613111890},{"date":"2021-05-28","current":-34.118192,"twenty":-61.102433,"median":-37.609185,"eighty":-22.049324,"marketCap":48941724842},{"date":"2021-06-04","current":-35.625611,"twenty":-60.979677,"median":-37.553441,"eighty":-22.116923,"marketCap":50861809206},{"date":"2021-06-10","current":-37.08623,"twenty":-60.769842,"median":-37.072786,"eighty":-22.258985,"marketCap":52986157863},{"date":"2021-06-18","current":-35.659842,"twenty":-60.584234,"median":-36.485136,"eighty":-22.270088,"marketCap":50494133476},{"date":"2021-06-25","current":-36.773665,"twenty":-60.537647,"median":-36.47778,"eighty":-22.279086,"marketCap":51923983534},{"date":"2021-06-30","current":-36.160141,"twenty":-60.48212,"median":-36.485136,"eighty":-22.301737,"marketCap":51188632076},{"date":"2021-07-09","current":-33.001535,"twenty":-60.380024,"median":-36.358401,"eighty":-22.333501,"marketCap":46572259032},{"date":"2021-07-16","current":-33.61015,"twenty":-60.247205,"median":-36.160141,"eighty":-22.684742,"marketCap":47430169066},{"date":"2021-07-23","current":-30.660269,"twenty":-60.081955,"median":-36.081197,"eighty":-23.212212,"marketCap":43263177469},{"date":"2021-07-30","current":-29.749657,"twenty":-60.025123,"median":-35.993074,"eighty":-23.780519,"marketCap":42119297422},{"date":"2021-08-06","current":-26.92917,"twenty":-59.948494,"median":-35.665203,"eighty":-24.743522,"marketCap":38034011542},{"date":"2021-08-13","current":-25.592675,"twenty":-59.918873,"median":-35.597545,"eighty":-24.965673,"marketCap":36195632896},{"date":"2021-08-20","current":-20.885732,"twenty":-59.826938,"median":-35.459665,"eighty":-24.434422,"marketCap":29454911194},{"date":"2021-08-27","current":-21.082492,"twenty":-59.613719,"median":-35.394103,"eighty":-23.176546,"marketCap":29863439782},{"date":"2021-09-03","current":-31.115126,"twenty":-59.45425,"median":-35.211108,"eighty":-23.023412,"marketCap":34806635697},{"date":"2021-09-10","current":-32.055246,"twenty":-59.359698,"median":-34.971061,"eighty":-23.122707,"marketCap":35950515744},{"date":"2021-09-17","current":-31.163903,"twenty":-59.210176,"median":-34.572405,"eighty":-23.198629,"marketCap":34847488556},{"date":"2021-09-24","current":-31.295563,"twenty":-59.102123,"median":-34.437371,"eighty":-23.212212,"marketCap":35010899991},{"date":"2021-09-30","current":-31.154784,"twenty":-59.047908,"median":-34.407249,"eighty":-23.447883,"marketCap":34970047132},{"date":"2021-10-08","current":-29.845898,"twenty":-58.976264,"median":-34.085183,"eighty":-24.385279,"marketCap":33499344216},{"date":"2021-10-15","current":-32.807984,"twenty":-58.969537,"median":-33.89682,"eighty":-24.581853,"marketCap":36849278637},{"date":"2021-10-22","current":-33.585285,"twenty":-58.897857,"median":-33.786096,"eighty":-24.856047,"marketCap":37993158684},{"date":"2021-10-29","current":-31.568779,"twenty":-58.531823,"median":-33.627637,"eighty":-25.019036,"marketCap":35623692873},{"date":"2021-11-05","current":-28.336247,"twenty":-58.387259,"median":-33.581277,"eighty":-25.13981,"marketCap":32028641299},{"date":"2021-11-12","current":-31.135474,"twenty":-58.165915,"median":-33.566565,"eighty":-25.305935,"marketCap":35337722862},{"date":"2021-11-19","current":-36.658551,"twenty":-57.747713,"median":-33.576384,"eighty":-25.505551,"marketCap":41547357399},{"date":"2021-11-26","current":-34.737009,"twenty":-57.465203,"median":-33.61015,"eighty":-25.671516,"marketCap":39382155883},{"date":"2021-12-03","current":-31.939354,"twenty":-57.376977,"median":-33.627637,"eighty":-26.141756,"marketCap":36277338614},{"date":"2021-12-10","current":-30.771813,"twenty":-57.264113,"median":-33.577269,"eighty":-26.43668,"marketCap":35010899991},{"date":"2021-12-17","current":-26.05017,"twenty":-56.996271,"median":-33.456271,"eighty":-26.43668,"marketCap":29618322630},{"date":"2021-12-24","current":-24.338156,"twenty":-56.834726,"median":-33.106388,"eighty":-25.505551,"marketCap":27698238266},{"date":"2021-12-31","current":-24.356969,"twenty":-56.799582,"median":-33.044261,"eighty":-25.17902,"marketCap":27779943984},{"date":"2022-01-07","current":-20.242995,"twenty":-23.086945,"median":-21.779811,"eighty":-19.899701,"marketCap":23000159504},{"date":"2022-01-14","current":-20.701287,"twenty":-22.600464,"median":-21.033383,"eighty":-20.391327,"marketCap":23572099527},{"date":"2022-01-21","current":-18.577865,"twenty":-21.986595,"median":-20.680988,"eighty":-19.350843,"marketCap":21202633717},{"date":"2022-01-28","current":-14.534275,"twenty":-21.562934,"median":-20.260299,"eighty":-18.52558,"marketCap":16545407814},{"date":"2022-02-04","current":-14.146452,"twenty":-21.41835,"median":-20.123216,"eighty":-17.613539,"marketCap":16096026367},{"date":"2022-02-11","current":-13.816944,"twenty":-21.209422,"median":-19.299968,"eighty":-14.985471,"marketCap":15752862353},{"date":"2022-02-18","current":-13.849256,"twenty":-20.857344,"median":-18.911796,"eighty":-14.543623,"marketCap":15867250357},{"date":"2022-02-25","current":-14.199347,"twenty":-20.701287,"median":-17.613539,"eighty":-14.146452,"marketCap":16308461232},{"date":"2022-03-04","current":-14.080132,"twenty":-20.680988,"median":-15.318994,"eighty":-14.146452,"marketCap":16177732084},{"date":"2022-03-11","current":-11.936356,"twenty":-20.490215,"median":-14.985471,"eighty":-13.996814,"marketCap":13693878269},{"date":"2022-03-18","current":-11.726724,"twenty":-20.277602,"median":-14.700549,"eighty":-13.379502,"marketCap":13399737686},{"date":"2022-03-25","current":-12.670051,"twenty":-20.242995,"median":-14.554967,"eighty":-13.072377,"marketCap":14478253158},{"date":"2022-04-01","current":-9.59311,"twenty":-20.003436,"median":-14.538949,"eighty":-12.331764,"marketCap":12697068515},{"date":"2022-04-08","current":-10.156641,"twenty":-19.508494,"median":-14.196743,"eighty":-11.833638,"marketCap":13448761116},{"date":"2022-04-14","current":-9.530673,"twenty":-19.333884,"median":-14.131899,"eighty":-11.51878,"marketCap":12599021653},{"date":"2022-04-22","current":-8.780037,"twenty":-19.299831,"median":-14.060726,"eighty":-10.573986,"marketCap":11389777033},{"date":"2022-04-29","current":-9.576611,"twenty":-19.278065,"median":-13.849256,"eighty":-10.115287,"marketCap":12223175352},{"date":"2022-05-06","current":-7.86231,"twenty":-19.112154,"median":-13.498553,"eighty":-9.579911,"marketCap":9951756403},{"date":"2022-05-13","current":-8.110711,"twenty":-18.577865,"median":-13.379502,"eighty":-9.437455,"marketCap":10082485551},{"date":"2022-05-20","current":-9.061494,"twenty":-18.447152,"median":-13.096379,"eighty":-8.947629,"marketCap":11422459320},{"date":"2022-05-27","current":-8.809867,"twenty":-17.613539,"median":-12.670051,"eighty":-8.780037,"marketCap":11095636450},{"date":"2022-06-02","current":-11.227787,"twenty":-16.802517,"median":-12.331764,"eighty":-8.803901,"marketCap":14216794862},{"date":"2022-06-10","current":-12.109337,"twenty":-15.675042,"median":-12.221978,"eighty":-8.825148,"marketCap":15229945760},{"date":"2022-06-17","current":-11.667379,"twenty":-15.244074,"median":-11.936356,"eighty":-8.923897,"marketCap":14658005737},{"date":"2022-06-24","current":-16.485913,"twenty":-15.494316,"median":-12.221978,"eighty":-9.038721,"marketCap":20794105129},{"date":"2022-06-30","current":-14.957001,"twenty":-15.895364,"median":-12.380422,"eighty":-9.079607,"marketCap":18833167906},{"date":"2022-07-08","current":-15.913959,"twenty":-16.531452,"median":-12.638751,"eighty":-9.104893,"marketCap":20058753670},{"date":"2022-07-15","current":-15.322331,"twenty":-16.45611,"median":-12.887919,"eighty":-9.149933,"marketCap":19134050754},{"date":"2022-07-22","current":-14.807486,"twenty":-16.221667,"median":-13.200862,"eighty":-9.216155,"marketCap":18503257872},{"date":"2022-07-29","current":-14.117198,"twenty":-15.979822,"median":-13.449665,"eighty":-9.360153,"marketCap":17662200696},{"date":"2022-08-05","current":-15.298986,"twenty":-15.838747,"median":-13.498553,"eighty":-9.442,"marketCap":19091997895},{"date":"2022-08-12","current":-15.143556,"twenty":-15.77936,"median":-13.923035,"eighty":-9.496416,"marketCap":18923786460},{"date":"2022-08-19","current":-14.616817,"twenty":-15.77936,"median":-14.080132,"eighty":-9.558236,"marketCap":18082729284},{"date":"2022-08-26","current":-14.756101,"twenty":-15.738632,"median":-14.060726,"eighty":-9.58651,"marketCap":21573116564},{"date":"2022-09-02","current":-14.751536,"twenty":-15.714766,"median":-14.080132,"eighty":-9.724865,"marketCap":21489010846},{"date":"2022-09-09","current":-14.98178,"twenty":-15.703366,"median":-14.105484,"eighty":-9.977712,"marketCap":21741327999},{"date":"2022-09-16","current":-13.542084,"twenty":-15.658514,"median":-14.086951,"eighty":-10.115287,"marketCap":19470473624},{"date":"2022-09-23","current":-12.107338,"twenty":-15.550768,"median":-14.041319,"eighty":-10.199224,"marketCap":17073460672},{"date":"2022-09-30","current":-12.91765,"twenty":-15.461818,"median":-13.978573,"eighty":-10.287783,"marketCap":18250940719},{"date":"2022-10-07","current":-16.281937,"twenty":-15.588998,"median":-14.018764,"eighty":-10.343921,"marketCap":23002913763},{"date":"2022-10-14","current":-15.674276,"twenty":-15.588998,"median":-14.040715,"eighty":-10.440625,"marketCap":21909539434},{"date":"2022-10-21","current":-18.781307,"twenty":-15.710601,"median":-14.070137,"eighty":-10.570074,"marketCap":26072772456},{"date":"2022-10-28","current":-18.085263,"twenty":-15.888888,"median":-14.117198,"eighty":-10.76408,"marketCap":25063503844},{"date":"2022-11-04","current":-18.001131,"twenty":-16.380537,"median":-14.170295,"eighty":-10.773453,"marketCap":25189662421},{"date":"2022-11-11","current":-17.246398,"twenty":-16.644748,"median":-14.199347,"eighty":-10.843556,"marketCap":24348605245},{"date":"2022-11-18","current":-21.310798,"twenty":-17.050284,"median":-14.308051,"eighty":-11.043704,"marketCap":29983688324},{"date":"2022-11-25","current":-18.980602,"twenty":-17.498612,"median":-14.382807,"eighty":-11.22006,"marketCap":26493301044},{"date":"2022-12-02","current":-19.013979,"twenty":-17.995008,"median":-14.534799,"eighty":-11.242055,"marketCap":26997935349},{"date":"2022-12-09","current":-24.062263,"twenty":-18.437795,"median":-14.543856,"eighty":-11.359054,"marketCap":34483344216},{"date":"2022-12-16","current":-24.530301,"twenty":-18.889555,"median":-14.574904,"eighty":-11.602588,"marketCap":35072084239},{"date":"2022-12-23","current":-25.228352,"twenty":-19.041941,"median":-14.612379,"eighty":-11.627361,"marketCap":36081352850},{"date":"2022-12-30","current":-24.983629,"twenty":-19.09779,"median":-14.616563,"eighty":-11.655751,"marketCap":36165458568},{"date":"2023-01-06","current":-26.109825,"twenty":-19.246994,"median":-14.727609,"eighty":-11.666513,"marketCap":38183995790},{"date":"2023-01-13","current":-27.482086,"twenty":-19.35432,"median":-14.788719,"eighty":-11.675194,"marketCap":40959484471},{"date":"2023-01-20","current":-27.207673,"twenty":-19.72973,"median":-14.927803,"eighty":-11.681264,"marketCap":40202533012},{"date":"2023-01-27","current":-29.02317,"twenty":-19.973183,"median":-14.953302,"eighty":-11.681837,"marketCap":42893915976},{"date":"2023-02-03","current":-27.684735,"twenty":-20.135985,"median":-14.979187,"eighty":-11.694899,"marketCap":41127695906},{"date":"2023-02-10","current":-25.345976,"twenty":-20.490215,"median":-14.987339,"eighty":-11.726724,"marketCap":37427044332},{"date":"2023-02-17","current":-24.322978,"twenty":-20.857344,"median":-15.034554,"eighty":-11.784491,"marketCap":35576718544},{"date":"2023-02-24","current":-24.100109,"twenty":-21.41835,"median":-15.060613,"eighty":-11.860367,"marketCap":34819767086},{"date":"2023-03-03","current":-25.36278,"twenty":-22.807081,"median":-15.131721,"eighty":-11.936356,"marketCap":36880357167},{"date":"2023-03-10","current":-22.900092,"twenty":-23.768741,"median":-23.203261,"eighty":-23.03994,"marketCap":33053547016},{"date":"2023-03-17","current":-29.09369,"twenty":-36.802165,"median":-25.36278,"eighty":-15.020812,"marketCap":38688630096},{"date":"2023-03-24","current":-25.324343,"twenty":-36.777216,"median":-25.389232,"eighty":-15.036479,"marketCap":34062815628},{"date":"2023-03-31","current":-25.456261,"twenty":-36.704597,"median":-25.488573,"eighty":-15.049117,"marketCap":33978709910},{"date":"2023-04-06","current":-27.774061,"twenty":-36.623868,"median":-25.540624,"eighty":-15.058257,"marketCap":37048568602},{"date":"2023-04-14","current":-29.730818,"twenty":-36.485136,"median":-25.637411,"eighty":-15.064541,"marketCap":39697898707},{"date":"2023-04-21","current":-26.784111,"twenty":-36.470425,"median":-25.724076,"eighty":-15.129637,"marketCap":35744929980},{"date":"2023-04-28","current":-27.207269,"twenty":-36.436465,"median":-26.010547,"eighty":-15.131721,"marketCap":36039299991},{"date":"2023-05-05","current":-28.335447,"twenty":-36.311562,"median":-26.064869,"eighty":-15.141189,"marketCap":37595255767},{"date":"2023-05-12","current":-27.159579,"twenty":-36.18971,"median":-26.086367,"eighty":-15.143863,"marketCap":35786982838},{"date":"2023-05-19","current":-24.342298,"twenty":-36.161524,"median":-26.085247,"eighty":-15.156,"marketCap":31623749817},{"date":"2023-05-25","current":-24.063272,"twenty":-36.158475,"median":-26.064869,"eighty":-15.180082,"marketCap":31203221229},{"date":"2023-06-02","current":-23.645458,"twenty":-36.149195,"median":-25.984476,"eighty":-15.257042,"marketCap":30488322630},{"date":"2023-06-09","current":-23.222359,"twenty":-36.112659,"median":-25.723039,"eighty":-15.312993,"marketCap":29899582606},{"date":"2023-06-16","current":-24.58122,"twenty":-36.07905,"median":-25.633881,"eighty":-15.343575,"marketCap":31497591241},{"date":"2023-06-23","current":-21.944137,"twenty":-36.043198,"median":-25.488573,"eighty":-15.365065,"marketCap":27965151102},{"date":"2023-06-30","current":-23.543047,"twenty":-35.998611,"median":-25.389232,"eighty":-15.403178,"marketCap":29731371171},{"date":"2023-07-07","current":-23.989446,"twenty":-35.969849,"median":-25.36278,"eighty":-15.455833,"marketCap":30236005477},{"date":"2023-07-14","current":-24.41425,"twenty":-35.912278,"median":-25.312393,"eighty":-15.498928,"marketCap":31203221229},{"date":"2023-07-21","current":-24.59436,"twenty":-35.843663,"median":-25.202538,"eighty":-15.562817,"marketCap":31287326947},{"date":"2023-07-28","current":-28.426335,"twenty":-35.766034,"median":-25.264398,"eighty":-15.623426,"marketCap":36123405709},{"date":"2023-08-04","current":-24.11733,"twenty":-35.704573,"median":-25.300444,"eighty":-15.66297,"marketCap":30698586924},{"date":"2023-08-11","current":-22.294,"twenty":-35.666275,"median":-25.201022,"eighty":-15.683018,"marketCap":28217468254},{"date":"2023-08-18","current":-21.752014,"twenty":-35.64615,"median":-25.173816,"eighty":-15.703366,"marketCap":27334358220},{"date":"2023-08-25","current":-22.10921,"twenty":-35.616771,"median":-25.07893,"eighty":-15.714766,"marketCap":27796939666},{"date":"2023-09-01","current":13.494719,"twenty":-35.601124,"median":-25.008455,"eighty":-15.66297,"marketCap":28974419713},{"date":"2023-09-08","current":13.695117,"twenty":-35.550756,"median":-24.944029,"eighty":-15.455833,"marketCap":29058525430},{"date":"2023-09-15","current":14.848421,"twenty":-35.47221,"median":-24.903626,"eighty":-15.308324,"marketCap":31749908394},{"date":"2023-09-22","current":14.814862,"twenty":-35.438003,"median":-24.827647,"eighty":-15.14371,"marketCap":31539644100},{"date":"2023-09-29","current":14.197918,"twenty":-35.396385,"median":-24.772153,"eighty":-15.059828,"marketCap":30278058336},{"date":"2023-10-06","current":13.889059,"twenty":-35.370319,"median":-24.700469,"eighty":-15.007069,"marketCap":29605212595},{"date":"2023-10-13","current":15.431226,"twenty":-35.30592,"median":-24.632761,"eighty":-14.979706,"marketCap":32843282722},{"date":"2023-10-20","current":14.94053,"twenty":-35.232247,"median":-24.59436,"eighty":-14.914724,"marketCap":31749908394},{"date":"2023-10-27","current":16.35255,"twenty":-35.175876,"median":-24.58122,"eighty":-14.756101,"marketCap":34735661368},{"date":"2023-11-03","current":17.592659,"twenty":-35.129074,"median":-24.511377,"eighty":-14.616308,"marketCap":37469097190},{"date":"2023-11-10","current":18.939266,"twenty":-34.971061,"median":-24.417444,"eighty":-14.569406,"marketCap":40328691589},{"date":"2023-11-17","current":18.319814,"twenty":-34.968612,"median":-24.399566,"eighty":-14.535322,"marketCap":39361475836},{"date":"2023-11-24","current":18.189638,"twenty":-34.895357,"median":-24.342298,"eighty":-14.371526,"marketCap":39403528695},{"date":"2023-12-01","current":18.752497,"twenty":-34.737009,"median":-24.330293,"eighty":-14.199347,"marketCap":40791273036},{"date":"2023-12-08","current":16.771041,"twenty":-34.685609,"median":-24.255162,"eighty":-14.117346,"marketCap":36333670003},{"date":"2023-12-15","current":17.832719,"twenty":-34.615488,"median":-24.15298,"eighty":-14.060142,"marketCap":38856841531},{"date":"2023-12-22","current":16.203086,"twenty":-34.602221,"median":-24.100109,"eighty":-13.960331,"marketCap":35282348533},{"date":"2023-12-29","current":17.826838,"twenty":-34.566441,"median":-24.075355,"eighty":-13.84838,"marketCap":39025052966},{"date":"2024-01-05","current":16.831364,"twenty":-34.502078,"median":-24.025855,"eighty":-13.7643,"marketCap":36585987156},{"date":"2024-01-12","current":17.634525,"twenty":-34.43816,"median":-23.91516,"eighty":-13.515965,"marketCap":38352207225},{"date":"2024-01-19","current":16.051677,"twenty":-34.428025,"median":-23.817977,"eighty":-13.388012,"marketCap":34861819945},{"date":"2024-01-26","current":16.269899,"twenty":-34.417805,"median":-23.667454,"eighty":-13.261099,"marketCap":35198242815},{"date":"2024-02-02","current":15.531605,"twenty":-34.408725,"median":-23.587311,"eighty":-13.092715,"marketCap":33558181322},{"date":"2024-02-09","current":15.823479,"twenty":-34.287198,"median":-23.509747,"eighty":-12.88456,"marketCap":34357185639},{"date":"2024-02-16","current":17.001239,"twenty":-34.118192,"median":-23.29296,"eighty":-12.670051,"marketCap":36922410026},{"date":"2024-02-23","current":17.733723,"twenty":-34.052175,"median":-23.261464,"eighty":-12.429079,"marketCap":38310154366},{"date":"2024-03-01","current":18.170113,"twenty":-33.918444,"median":-23.222586,"eighty":-12.109337,"marketCap":39277370119},{"date":"2024-03-08","current":18.375936,"twenty":-33.875196,"median":-23.212231,"eighty":-11.784491,"marketCap":39739951566},{"date":"2024-03-15","current":20.221708,"twenty":-33.786096,"median":-23.186995,"eighty":-11.680404,"marketCap":43692920293},{"date":"2024-03-22","current":17.596046,"twenty":-33.777607,"median":-23.165857,"eighty":-11.598761,"marketCap":38772735813},{"date":"2024-03-28","current":17.863111,"twenty":-33.671621,"median":-23.133172,"eighty":-11.174522,"marketCap":39235317260},{"date":"2024-04-05","current":17.790526,"twenty":-33.631134,"median":-23.073507,"eighty":-10.781195,"marketCap":39050158637},{"date":"2024-04-12","current":19.515107,"twenty":-33.600204,"median":-23.002422,"eighty":-10.363031,"marketCap":42859930212},{"date":"2024-04-19","current":17.322126,"twenty":-33.582079,"median":-22.887987,"eighty":-9.922708,"marketCap":38011130026},{"date":"2024-04-26","current":19.239838,"twenty":-33.576561,"median":-22.815578,"eighty":-9.479287,"marketCap":42167244471},{"date":"2024-05-03","current":19.371749,"twenty":-33.573712,"median":-22.807081,"eighty":-9.18811,"marketCap":42427001624},{"date":"2024-05-10","current":19.700553,"twenty":-33.522448,"median":-22.755385,"eighty":-8.970402,"marketCap":43249565941},{"date":"2024-05-17","current":19.23578,"twenty":-33.345978,"median":-22.735553,"eighty":-8.780037,"marketCap":42167244471},{"date":"2024-05-24","current":14.667701,"twenty":-33.217784,"median":-22.607363,"eighty":-8.675073,"marketCap":32080008370},{"date":"2024-05-31","current":17.401421,"twenty":-33.106388,"median":-22.460124,"eighty":-8.554056,"marketCap":38097715744},{"date":"2024-06-07","current":16.096502,"twenty":-33.061925,"median":-22.417733,"eighty":-8.291628,"marketCap":35197094204},{"date":"2024-06-14","current":15.794192,"twenty":-33.047794,"median":-22.339227,"eighty":-8.117822,"marketCap":34504408463},{"date":"2024-06-21","current":14.159201,"twenty":-33.01008,"median":-22.315076,"eighty":-7.860137,"marketCap":30867808324},{"date":"2024-06-28","current":14.999486,"twenty":-32.90826,"median":-22.280642,"eighty":13.494356,"marketCap":32686108394},{"date":"2024-07-05","current":15.459781,"twenty":-32.881624,"median":-22.258985,"eighty":13.627238,"marketCap":33681844146},{"date":"2024-07-12","current":15.952998,"twenty":-32.86657,"median":-22.065202,"eighty":13.703744,"marketCap":34807458475},{"date":"2024-07-19","current":15.972541,"twenty":-32.832239,"median":-21.944137,"eighty":13.863497,"marketCap":34850751334},{"date":"2024-07-26","current":16.071567,"twenty":-32.814226,"median":-21.7966,"eighty":14.148348,"marketCap":35197094204},{"date":"2024-08-02","current":16.61499,"twenty":-32.811697,"median":-21.752014,"eighty":14.411832,"marketCap":36366001392},{"date":"2024-08-09","current":17.212345,"twenty":-32.808943,"median":-21.597174,"eighty":14.509977,"marketCap":37924544308},{"date":"2024-08-16","current":17.657405,"twenty":-32.804956,"median":-21.439655,"eighty":14.640353,"marketCap":38920280061},{"date":"2024-08-23","current":17.9547,"twenty":-32.79969,"median":-21.418042,"eighty":14.703604,"marketCap":39742844378},{"date":"2024-08-30","current":-52.624506,"twenty":-32.804956,"median":-21.417734,"eighty":14.818346,"marketCap":42513587341},{"date":"2024-09-06","current":-51.635037,"twenty":-32.832239,"median":-21.438942,"eighty":14.78042,"marketCap":41734315883},{"date":"2024-09-13","current":-66.216902,"twenty":-33.018625,"median":-21.520592,"eighty":14.703604,"marketCap":53380094900},{"date":"2024-09-20","current":-69.932725,"twenty":-33.173226,"median":-21.714319,"eighty":14.662246,"marketCap":56713645028},{"date":"2024-09-27","current":-71.531113,"twenty":-33.576561,"median":-21.771586,"eighty":14.652247,"marketCap":58358773662},{"date":"2024-10-04","current":-79.320454,"twenty":-33.638129,"median":-21.813706,"eighty":14.649255,"marketCap":64419773894},{"date":"2024-10-10","current":-69.213885,"twenty":-33.875196,"median":-21.986037,"eighty":14.648182,"marketCap":55847787852},{"date":"2024-10-18","current":-74.646599,"twenty":-34.399868,"median":-22.081407,"eighty":14.635134,"marketCap":59917316579},{"date":"2024-10-25","current":-77.719883,"twenty":-34.441314,"median":-22.265924,"eighty":14.560741,"marketCap":62380223732},{"date":"2024-11-01","current":-76.214752,"twenty":-34.685609,"median":-22.294,"eighty":14.556702,"marketCap":61213399403},{"date":"2024-11-08","current":-76.2814,"twenty":-34.971061,"median":-22.333531,"eighty":14.515997,"marketCap":60989010109},{"date":"2024-11-15","current":-78.00551,"twenty":-35.320815,"median":-22.40582,"eighty":14.505964,"marketCap":61707055850},{"date":"2024-11-22","current":-81.958791,"twenty":-35.480573,"median":-22.437728,"eighty":14.479729,"marketCap":64803628107},{"date":"2024-11-29","current":-83.036127,"twenty":-35.659842,"median":-22.470599,"eighty":14.463817,"marketCap":65611429565},{"date":"2024-12-06","current":-74.237179,"twenty":-35.878177,"median":-22.720101,"eighty":14.435399,"marketCap":58520727875},{"date":"2024-12-13","current":-72.615659,"twenty":-36.070462,"median":-22.745547,"eighty":14.396121,"marketCap":57129514252},{"date":"2024-12-20","current":-69.730236,"twenty":-36.160141,"median":-22.79318,"eighty":14.28027,"marketCap":54616354159},{"date":"2024-12-27","current":-68.121477,"twenty":-36.342788,"median":-22.81524,"eighty":14.230859,"marketCap":53314896254},{"date":"2025-01-03","current":-66.794572,"twenty":-36.589185,"median":-22.863096,"eighty":14.182431,"marketCap":52327583360},{"date":"2025-01-10","current":-64.575988,"twenty":-36.921451,"median":-22.916115,"eighty":14.151966,"marketCap":50397835432},{"date":"2025-01-17","current":-67.97132,"twenty":-37.388459,"median":-23.037405,"eighty":14.124517,"marketCap":53090506960},{"date":"2025-01-24","current":-71.487894,"twenty":-37.630978,"median":-23.112092,"eighty":14.06824,"marketCap":56187079217},{"date":"2025-01-28","current":-69.159217,"twenty":-37.749998,"median":-23.133265,"eighty":14.036856,"marketCap":54616354159},{"date":"2025-02-07","current":-74.204707,"twenty":-38.720974,"median":-23.179575,"eighty":13.91548,"marketCap":58296338581},{"date":"2025-02-14","current":-68.942526,"twenty":-39.742666,"median":-23.199597,"eighty":13.854976,"marketCap":54032941995},{"date":"2025-02-21","current":-78.532535,"twenty":-40.936164,"median":-23.213534,"eighty":13.833941,"marketCap":61886567285},{"date":"2025-02-28","current":-83.363188,"twenty":-41.78603,"median":-23.229233,"eighty":13.752998,"marketCap":65476795989},{"date":"2025-03-07","current":-82.972913,"twenty":-43.765472,"median":-23.273351,"eighty":13.720056,"marketCap":65431918130},{"date":"2025-03-14","current":-81.918752,"twenty":-44.36559,"median":-23.404228,"eighty":13.69943,"marketCap":64624116672},{"date":"2025-03-21","current":-77.113549,"twenty":-46.703645,"median":-23.571971,"eighty":13.681934,"marketCap":60809498674},{"date":"2025-03-28","current":-85.082441,"twenty":-50.561624,"median":-23.656456,"eighty":13.67268,"marketCap":66957765329},{"date":"2025-04-03","current":-139.968555,"twenty":-51.651807,"median":-23.75284,"eighty":13.662257,"marketCap":77100161418},{"date":"2025-04-11","current":-135.149196,"twenty":-52.531592,"median":-23.854164,"eighty":13.627238,"marketCap":73779199867},{"date":"2025-04-17","current":-136.201828,"twenty":-53.202931,"median":-23.974596,"eighty":13.597708,"marketCap":74452367749},{"date":"2025-04-25","current":-162.080631,"twenty":-54.264543,"median":-23.982021,"eighty":13.592632,"marketCap":88770184906},{"date":"2025-05-02","current":-143.58439,"twenty":-55.295104,"median":-23.989446,"eighty":13.587555,"marketCap":78807100452},{"date":"2025-05-09","current":-136.980788,"twenty":-56.345373,"median":-23.982021,"eighty":13.592632,"marketCap":75710466095},{"date":"2025-05-16","current":-134.501562,"twenty":-57.376977,"median":-23.982021,"eighty":13.592632,"marketCap":74947527196},{"date":"2025-05-23","current":-133.538341,"twenty":-57.747713,"median":-23.982021,"eighty":13.592632,"marketCap":74633375884},{"date":"2025-05-30","current":-133.993142,"twenty":-58.91872,"median":-23.982021,"eighty":13.592632,"marketCap":75216799748},{"date":"2025-06-06","current":-131.180073,"twenty":-59.359698,"median":-23.982021,"eighty":13.592632,"marketCap":73825558226}],"updateTime":1749285609826}}}